James Investment Research Inc. raised its position in HCA Holdings, Inc. (NYSE:HCA) by 552.7% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 16,644 shares of the company’s stock after buying an additional 14,094 shares during the period. James Investment Research Inc.’s holdings in HCA Holdings were worth $1,452,000 as of its most recent filing with the SEC.
Other institutional investors have also recently bought and sold shares of the company. BlackRock Inc. increased its position in HCA Holdings by 2,549.4% in the first quarter. BlackRock Inc. now owns 20,099,811 shares of the company’s stock valued at $1,788,682,000 after buying an additional 19,341,168 shares during the last quarter. Vanguard Group Inc. increased its position in HCA Holdings by 1.9% in the first quarter. Vanguard Group Inc. now owns 19,576,992 shares of the company’s stock valued at $1,742,157,000 after buying an additional 361,027 shares during the last quarter. State Street Corp increased its position in HCA Holdings by 2.2% in the first quarter. State Street Corp now owns 13,217,212 shares of the company’s stock valued at $1,176,199,000 after buying an additional 290,636 shares during the last quarter. Harris Associates L P boosted its stake in shares of HCA Holdings by 0.9% in the first quarter. Harris Associates L P now owns 12,214,476 shares of the company’s stock worth $1,086,966,000 after buying an additional 105,317 shares during the last quarter. Finally, FMR LLC boosted its stake in shares of HCA Holdings by 15.8% in the first quarter. FMR LLC now owns 7,763,884 shares of the company’s stock worth $690,908,000 after buying an additional 1,059,925 shares during the last quarter. Institutional investors and hedge funds own 75.69% of the company’s stock.
HCA Holdings, Inc. (NYSE HCA) traded up 0.19% during trading on Monday, reaching $79.52. 2,035,971 shares of the company were exchanged. HCA Holdings, Inc. has a 1-year low of $67.00 and a 1-year high of $91.03. The company’s 50-day moving average price is $83.56 and its 200-day moving average price is $84.33. The stock has a market capitalization of $28.73 billion, a P/E ratio of 10.66 and a beta of 0.67.
HCA Holdings (NYSE:HCA) last announced its earnings results on Tuesday, July 25th. The company reported $1.75 EPS for the quarter, missing analysts’ consensus estimates of $1.80 by $0.05. The business had revenue of $10.73 billion during the quarter, compared to analyst estimates of $10.76 billion. HCA Holdings had a net margin of 6.64% and a negative return on equity of 48.08%. The business’s revenue was up 4.0% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.66 earnings per share. On average, equities analysts forecast that HCA Holdings, Inc. will post $7.17 EPS for the current year.
ILLEGAL ACTIVITY WARNING: “HCA Holdings, Inc. (HCA) Shares Bought by James Investment Research Inc.” was posted by StockNewsTimes and is the sole property of of StockNewsTimes. If you are viewing this news story on another domain, it was copied illegally and reposted in violation of US and international copyright legislation. The original version of this news story can be viewed at https://stocknewstimes.com/2017/08/14/james-investment-research-inc-purchases-14094-shares-of-hca-holdings-inc-hca-updated-updated-updated.html.
A number of brokerages have issued reports on HCA. Cantor Fitzgerald reissued a “buy” rating and set a $95.00 target price on shares of HCA Holdings in a report on Monday, April 17th. Zacks Investment Research cut shares of HCA Holdings from a “buy” rating to a “hold” rating in a report on Friday, July 14th. BidaskClub cut shares of HCA Holdings from a “hold” rating to a “sell” rating in a report on Monday, July 24th. Argus assumed coverage on shares of HCA Holdings in a report on Wednesday, June 28th. They issued a “buy” rating and a $100.00 price target on the stock. Finally, Leerink Swann raised shares of HCA Holdings from a “market perform” rating to an “outperform” rating and upped their price target for the stock from $92.00 to $100.00 in a report on Tuesday, June 6th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and twelve have assigned a buy rating to the company’s stock. HCA Holdings currently has a consensus rating of “Buy” and a consensus target price of $93.06.
In related news, SVP Sandra L. Morgan sold 5,915 shares of the business’s stock in a transaction dated Wednesday, May 17th. The shares were sold at an average price of $82.74, for a total value of $489,407.10. Following the sale, the senior vice president now directly owns 2,420 shares in the company, valued at approximately $200,230.80. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, insider Michael S. Cuffe sold 2,150 shares of the business’s stock in a transaction dated Thursday, June 15th. The stock was sold at an average price of $84.86, for a total transaction of $182,449.00. The disclosure for this sale can be found here. Insiders sold a total of 135,967 shares of company stock worth $11,472,759 over the last three months. 2.90% of the stock is currently owned by corporate insiders.
HCA Holdings Company Profile
HCA Healthcare, Inc, formerly HCA Holdings, Inc, is a holding company. The Company, through its subsidiaries, owns and operates hospitals and related healthcare entities. As of December 31, 2016, the Company operated in two geographically organized groups, including the National and American Groups. As of December 31, 2016, the National Group included 84 hospitals, which were located in Alaska, California, Florida, southern Georgia, Idaho, Indiana, northern Kentucky, Nevada, New Hampshire, South Carolina, Utah and Virginia.
Receive News & Ratings for HCA Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.
